Work

A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients with advanced solid tumors

Year: 2007

Type: article

Study design: Clinical Trial

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s00262-007-0357-5

Authors: Matthew G. Fury, Allan Lipton, Katherine M. Smith, Corinne B. Winston, David G. Pfister

Institutions: Memorial Sloan Kettering Cancer Center, Penn State Milton S. Hershey Medical Center

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2006885022

FWCI: 2.036

Cites: 26

Cited by: 89

Related to: 10